Valeo Pharma Profit Margin

Valeo Pharma posts a profit margin of -60.18% as of July 2024. That compares with -53.52% in the prior-year period — down 12.4% year over year. That is below the sector sector average of 13.09%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Valeo Pharma's profit margin was -53.52%. The latest reading is -60.18% — a 12.4% year-over-year decrease (period ending July 2024). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 13.09% is typical. Valeo Pharma's -60.18% is lower that level. That is roughly 559.8% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Valeo Pharma's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -60.18% as of July 2024; use YoY and peer views to separate noise from signal.

Context for VPHIF's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.09%), and (3) consistency with growth and profitability. This page covers the first two; Valeo Pharma's other metric pages and overview cover the third.